Lin Qiu | Genetic Disease | Best Researcher Award

Prof. Lin Qiu | Genetic Disease | Best Researcher Award

Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University | China

Prof. Lin Qiu, Ph.D., is an Associate Professor, Deputy Chief Physician, and Master’s Supervisor in the Department of Nuclear Medicine at the Affiliated Hospital of Southwest Medical University, where he has established himself as a leading scholar and clinician in the field of nuclear medicine. He holds multiple prestigious academic positions, including Young Member of the Nuclear Medicine Physicians Branch of the Chinese Medical Doctor Association, Member of the Nuclear Medicine Committee of the Sichuan Medical Association, Member of the Nuclear Medicine Branch of both the Sichuan Medical Doctor Association and the Sichuan Health and Medical Promotion Association, and Vice Chairperson of the Nuclear Medicine Committee of the Chengdu Biomedical Information Society. Dr. Lin Qiu has led or participated in more than ten scientific research projects, secured four invention patents as first inventor, and published over 30 academic papers as first or corresponding author - 27 of which are SCI-indexed with a highest impact factor of 29.146 - in top-tier journals such as Radiology, EJNMMI, CNM, JMC, and European Radiology. His academic contributions also include co-authoring three nuclear medicine monographs and three clinical guidelines. In recognition of his outstanding achievements, he has received numerous honors, including the Sichuan Province Defense Science and Technology Elite Talent Project Award, the First Prize for Scientific and Technological Achievement Transformation of the Sichuan Medical Association, the Sichuan Medical Association Young Excellent Paper Award, and the Third Prize for Sichuan Province Science and Technology Progress.

Profiles: Scopus

Featured Publications

"AComparative Evaluation of [68Ga]Ga-Fibroblast Activation Protein Inhibitor vs. [18F]FDG as a Novel Radiotracer for Biology-Guided Image Radiotherapy", Prof. Lin Qiu., 2025

"Development and Evaluation of [68Ga]Ga-DOTA-BT1718: A Novel Imaging Agent Targeting MT1-MMP for Malignant Tumor Diagnosis",Prof. Lin Qiu., 2025

"18F-FDG PET/CT Versus 68Ga-FAPI PET/CT in a Case of Isolated Nodal-Type Follicular Dendritic Cell Sarcoma", Prof. Lin Qiu., 2025